Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Surgical techniques for shoulder osteoarthritis treatment

Official title: Comparison of Shoulder Arthroplasty Techniques in the Treatment of Glenohumeral Osteoarthritis: Protocol

Run by Ottawa Hospital Research Institute · NCT02966886 · Data updated 2026-11-12

This study is testing different surgical methods for treating shoulder osteoarthritis to see which one helps patients feel better and improves their quality of life after surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment216 (estimated)
SponsorOttawa Hospital Research Institute
Academic / other
Locations1 site (Ottawa, Ontario)
StatusRecruiting
StartedApril 23, 2017
Main results expectedDecember 2027
Study endsDecember 2028
Registry record updatedApril 30, 2024
Trial IDNCT02966886 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women of any age with advanced osteoarthritis of the glenohumeral joint who have not responded to standard non-surgical management.

Probably not a fit

Patients with mild osteoarthritis or those who have not yet attempted non-surgical management may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates different surgical techniques for treating osteoarthritis of the shoulder, specifically focusing on total shoulder arthroplasty (TSA). Patients with varying degrees of glenoid retroversion will be randomly assigned to receive either TSA with eccentric glenoid reaming, augmented glenoid component implantation, or posterior glenoid bone grafting. The primary objective is to assess patient outcomes using the Western Ontario Osteoarthritis of the Shoulder Index (WOOS) score at multiple post-operative intervals. Secondary objectives include evaluating component survivorship and quality of life improvements through various assessment tools over a two-year period.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing shoulder arthroplasty.

How similar studies have gone: Other studies have shown promising results with similar surgical approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient Population The target population is both men and women of any age with advanced osteoarthritis of the glenohumeral joint who are considered by the treating surgeon to be a candidate for shoulder replacement. The type of arthritic process will not be considered a deciding factor. The arthritis must be amenable to treatment using either a humeral head replacement (stemmed or stem-less), or a standard total shoulder replacement.

Inclusion Criteria

1. Patients who have failed standard non-surgical management of their shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:

   1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
   2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
   3. Activity modification
2. Patients will present with a glenoid retroversion between 10-26 degrees.
3. Imaging, and intra-operative findings confirming advanced humeral head cartilage loss, with or without glenoid cartilage loss.
4. Age 18 years or older

Exclusion Criteria

1. \< 10 degrees / \> 27 degrees of glenoid retroversion
2. Active joint or systemic infection
3. Rotator cuff arthropathy
4. Significant muscle paralysis
5. Charcot's arthropathy
6. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
7. Unable to understand the consent form/process
8. Pregnancy
9. Psychiatric illness that precludes informed consent
10. Unwilling to be followed for the duration of the study
11. Retroversion cannot be surgically corrected to within 10 degrees of neutral
12. History of previous shoulder surgery on affected side
13. Rheumatoid arthritis in the affected shoulder

Where it's running

  • The Ottawa Hospital
    Ottawa, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Peter Lapner, MD — The Ottawa Hospital
  • Study coordinator: Peter Lapner, MD
  • Email: plapner@toh.ca
  • Phone: 613-737-8899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.